Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
210
NMPA:210
Drug Approvals
Lysine Hydrochloride and Calcium Hydrogen Phosphate Granules
- Product Name
- 赖氨酸磷酸氢钙颗粒
- Approval Number
- 国药准字H14023847
- Approval Date
- Sep 9, 2024
NMPA
Nifedipine Controlled-release Tablets
- Product Name
- 硝苯地平控释片
- Approval Number
- 国药准字H20244498
- Approval Date
- Jul 30, 2024
NMPA
Nifedipine Controlled-release Tablets
- Product Name
- 硝苯地平控释片
- Approval Number
- 国药准字H20244499
- Approval Date
- Jul 30, 2024
NMPA
Lysine Acetylsalicylate for Injection
- Product Name
- 注射用赖氨匹林
- Approval Number
- 国药准字H20084235
- Approval Date
- Jul 26, 2023
NMPA
Lysine Acetylsalicylate for Injection
- Product Name
- 注射用赖氨匹林
- Approval Number
- 国药准字H20084234
- Approval Date
- Jul 26, 2023
NMPA
Trimetazidine Hydrochloride Tablets
- Product Name
- 盐酸曲美他嗪片
- Approval Number
- 国药准字H20123233
- Approval Date
- Jul 25, 2022
NMPA
Xanthinol Nicotinate Tablets
- Product Name
- 烟酸占替诺片
- Approval Number
- 国药准字H14023642
- Approval Date
- Apr 18, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 21
- Next
Clinical Trials
No trials found
News
No news found